Baker Bros. Advisors Lp - Net Worth and Insider Trading

Over the past 18 months, Baker Bros. Advisors Lp made 2 insider transaction in IGM Biosciences Inc (IGMS) with a net purchase of 928,010. Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 16,402 shares made by Lisa Lynn Decker , a net sale of 18,871 shares made by Misbah Tahir , and a net sale of 5,319 shares made by Steven Weber .

In summary, during the past 3 months, insiders sold 21,993 shares of IGM Biosciences Inc (IGMS) in total and bought 0 shares, with a net sale of 21,993 shares. During the past 18 months, 129,674 shares of IGM Biosciences Inc (IGMS) were sold and 928,010 shares were bought by its insiders, resulting in a net purchase of 798,336 shares.

IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 52,105 shares made by Barry P Flannelly , a net sale of 4,624 shares made by Thomas Tray , and a net sale of 31,325 shares made by Steven H Stein .

In summary, during the past 3 months, insiders sold 46,827 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 46,827 shares. During the past 18 months, 133,443 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,443 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Kodiak Sciences Inc (KOD). Other recent insider transactions involving Kodiak Sciences Inc (KOD) include a net sale of 4,432 shares made by John A. Borgeson ,

In summary, during the past 3 months, insiders sold 0 shares of Kodiak Sciences Inc (KOD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,432 shares of Kodiak Sciences Inc (KOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,432 shares.

Kodiak Sciences Inc (KOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 953,909 shares made by Krishna Vaddi , a net purchase of 163,075 shares made by Andrew Combs , and a net purchase of 25,000 shares made by Bryant David Lim .

In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 932,021 shares, with a net purchase of 932,021 shares. During the past 18 months, 0 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,141,984 shares were bought by its insiders, resulting in a net purchase of 1,141,984 shares.

Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 132,426 shares made by Eben Tessari , a net sale of 139,852 shares made by Mark Ragosa , and a net sale of 309,021 shares made by Sanj K Patel .

In summary, during the past 3 months, insiders sold 108,119 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 108,119 shares. During the past 18 months, 813,051 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 813,051 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 1 insider transaction in Atreca Inc (BCEL) with a net sale of 274,739. Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 20,788 shares made by Tito Serafini ,

In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,527 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,527 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 3 insider transaction in BeiGene Ltd (ONC) with a net sale of 2,869,844. Other recent insider transactions involving BeiGene Ltd (ONC) include a net sale of 361,154 shares made by John Oyler , a net sale of 171,032 shares made by Xiaobin Wu , and a net sale of 4,882 shares made by Chan Henry Lee .

In summary, during the past 3 months, insiders sold 1,178,666 shares of BeiGene Ltd (ONC) in total and bought 0 shares, with a net sale of 1,178,666 shares. During the past 18 months, 21,397,509 shares of BeiGene Ltd (ONC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 21,397,509 shares.

BeiGene Ltd (ONC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 45,152 shares made by Mark C. Schneyer , a net sale of 14,246 shares made by James Kihara , and a net sale of 37,363 shares made by Brendan Teehan .

In summary, during the past 3 months, insiders sold 14,169 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 14,169 shares. During the past 18 months, 199,041 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 199,041 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 10,620 shares made by David R Epstein , and a net sale of 8,785 shares made by Vaughn B Himes .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,405 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,405 shares.

Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net purchase of 4,262,301 shares made by Ecor1 Capital, Llc , a net sale of 81,195 shares made by Kenneth Galbraith , and a net sale of 30,999 shares made by Paul Andrew Moore .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 2,288,696 shares, with a net purchase of 2,288,696 shares. During the past 18 months, 130,184 shares of Zymeworks Inc (ZYME) were sold and 4,262,301 shares were bought by its insiders, resulting in a net purchase of 4,132,117 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aceragen Inc (ACGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 5,907 shares made by Benjamin Hickey , and a net sale of 5,515 shares made by Jamie Christensen .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,422 shares of Mirati Therapeutics Inc (MRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,422 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 188,715 shares made by Joseph Shulman , a net sale of 141,432 shares made by Jennifer Chien , and a net sale of 107,577 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 155,744 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 155,744 shares. During the past 18 months, 807,890 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 807,890 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 2,000 shares made by Nancy J Hutson , a net purchase of 36,300 shares made by Anthony Doyle , and a net purchase of 30,000 shares made by Jon P Stonehouse .

In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,987 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 156,614 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 16,773 shares made by Laura Sepp-lorenzino , a net sale of 12,991 shares made by Eliana Clark , and a net sale of 46,030 shares made by John M. Leonard .

In summary, during the past 3 months, insiders sold 265 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 265 shares. During the past 18 months, 123,236 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 123,236 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in XOMA Royalty Corp (XOMA). Other recent insider transactions involving XOMA Royalty Corp (XOMA) include a net purchase of 7,284 shares made by Bradley Sitko , a net sale of 8,775 shares made by Thomas M. Burns , and a net sale of 650,717 shares made by Biotechnology Value Fund L P .

In summary, during the past 3 months, insiders sold 650,717 shares of XOMA Royalty Corp (XOMA) in total and bought 28,134 shares, with a net sale of 622,583 shares. During the past 18 months, 682,373 shares of XOMA Royalty Corp (XOMA) were sold and 28,284 shares were bought by its insiders, resulting in a net sale of 654,089 shares.

XOMA Royalty Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XOMA Royalty Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Royalty Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XOMA Royalty Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Talis Biomedical Corp (TLIS). Other recent insider transactions involving Talis Biomedical Corp (TLIS) include a net purchase of 45,133 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Talis Biomedical Corp (TLIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Talis Biomedical Corp (TLIS) were sold and 45,133 shares were bought by its insiders, resulting in a net purchase of 45,133 shares.

Talis Biomedical Corp (TLIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in DBV Technologies SA (DBVT). Other recent insider transactions involving DBV Technologies SA (DBVT) include a net sale of 8,929 shares made by Pharis Mohideen , a net purchase of 17,094 shares made by Daniel Tasse , and a net purchase of 1,825 shares made by Adora Ndu .

In summary, during the past 3 months, insiders sold 600 shares of DBV Technologies SA (DBVT) in total and bought 0 shares, with a net sale of 600 shares. During the past 18 months, 1,937 shares of DBV Technologies SA (DBVT) were sold and 1,892 shares were bought by its insiders, resulting in a net sale of 45 shares.

DBV Technologies SA (DBVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 7,000 shares made by Jeffrey W. Albers , and a net sale of 18,531 shares made by Scott L Burrows .

In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,531 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 10,900 shares made by Dipal Doshi , a net sale of 62,279 shares made by Natarajan Sethuraman , and a net sale of 37,960 shares made by Kory James Wentworth .

In summary, during the past 3 months, insiders sold 1,784 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 1,784 shares. During the past 18 months, 232,656 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 187,288 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in TScan Therapeutics Inc (TCRX). Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 20,000 shares made by Barbara Klencke , a net purchase of 132,747 shares made by Lynx1 Capital Management Lp , and a net sale of 164,686 shares made by Zoran Zdraveski .

In summary, during the past 3 months, insiders sold 0 shares of TScan Therapeutics Inc (TCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 164,686 shares of TScan Therapeutics Inc (TCRX) were sold and 181,894 shares were bought by its insiders, resulting in a net purchase of 17,208 shares.

TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 6 insider transaction in Madrigal Pharmaceuticals Inc (MDGL) with a net purchase of 424,685. Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net sale of 28,621 shares made by Robert E. Waltermire , a net sale of 78,901 shares made by Rebecca Taub , and a net sale of 44,959 shares made by Fred B Craves .

In summary, during the past 3 months, insiders sold 75,838 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 75,838 shares. During the past 18 months, 397,456 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 27,229 shares.

Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.